TrialHaematologica2019

Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV.

Christian Michel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.